SeaSpine Holdings Corporation public offering worth US$101 million acted on by DLA Piper
DLA Piper represented SeaSpine Holdings Corporation (SeaSpine) in its recent public offering of 5,175,000 shares of its common stock at a price of $19.50 per share, including the exercise of the underwriters' option to purchase 675,000 shares of common stock (less underwriting discounts and commissions).
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine.
The team from DLA Piper was led by Partner – Michael Kagnoff and also comprised of Patrick O'Malley (Partner) and Zamzama Azizi (associate). Michael Kagnoff stated in a Press Release, "We were thrilled to assist SeaSpine with this public offering, which demonstrated the strength of our life sciences capital markets capabilities and ability to facilitate complex transactions and bring value to our clients."